2025 Reed Conference for Pharmacy

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants of the 2025 Reed Conference will receive 5 contact hours (0.5 CEU), including one hour of pharmacy law. An additional hour of law credit will be available via home study (0.1 CEU).

Requirements for Credit

In order to receive credit, the participant must be present the entirety of each presentation and complete the post-tests, and evaluation form for each session. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from the CPE Monitor.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Disclosures

Snehal Bhatt, has no relevant financial relationships with ineligible companies within the last 24 months to disclose.

Judy Cheng, has no relevant financial relationships with ineligible companies within the last 24 months to disclose.

Jennifer D. Goldman, holds relevant financial relationships with ineligible companies. She is a member of the speaker's bureau for Abbott Diabetes, Novo Nordisk, Sanofi, Lilly, Amgen, CeQur, and Xeris. She will be discussing pipeline information regarding continuous glucose monitoring, including use over the counter and for ketoacidosis. The content developed and presented does not endorse the product lines or solutions produced or offered by Abbott Diabetes, Novo Nordisk, Sanofi, Lilly, Amgen, CeQur, and Xeris.

Erika Felix-Getzik, has no relevant financial relationships with ineligible companies within the last 24 months to disclose.

Timothy Fensky, has no relevant financial relationships with ineligible companies within the last 24 months to disclose.

Davida F. Kruger, holds relevant financial relationships with ineligible companies. She is a consultant to Abbott Diabetes, CeQur, Lilly, MannKind, Medtronics, Ascentia, Insulet, Embecta, Arcor, Structure Therapeutics, and Proteomics. She is a member of the Speakers Bureaus of Dexcom, CeQur, Lilly, Novo Nordisk, Abbott, Tandem, and Insulet. She conducts institutional research for Abbott, Tandem, Insulet, Embecta, and Sequel. The content developed and presented does not endorse the product lines or solutions produced or offered by Abbott Diabetes, CeQur, Lilly, MannKind, Medtronics, Ascentia, Insulet, Embecta, Arcor, Structure Therapeutics, Proteomics, Dexcom, Novo Nordisk, or Tandem.

Eden M. Miller, holds relevant financial relationships with ineligible companies. She is a member of the Speaker Research Advisory Board for Abbott, and the Speaker Advisory Boards for Eli Lilly, Novo Nordisk, Bayer, Boehringer Ingelheim, Embecta, and Insulet. The content developed and presented does not endorse the product lines or solutions produced or offered by Abbott, Eli Lilly, Novo Nordisk, Bayer, Boehringer Ingelheim, Embecta, or Insulet.

Samar Nicolas, has no relevant financial relationships with ineligible companies within the last 24 months to disclose.

Phung C. On, has no relevant financial relationships with ineligible companies within the last 24 months to disclose.

Massachusetts College of Pharmacy and Health Sciences continuing education staff members have no relevant financial relationships with ineligible companies within the last 24 months to disclose.

No funding from industry provided for this event. No exhibitors will be present.

Putnam Club - Gillette Stadium
2nd Floor
1 Patriot Place
Foxborough, MA 02035

Google Map Directions

Directions from 95

Take Interstate 95 to Exit 19 onto Route 1 South. Merge onto Route 1 South and follow for approximately 3 miles until you see Gillette Stadium at Patriot Place on your left. Once you reach the stadium, take a left at the second set of lights (CVS Pharmacy on corner) and take your first right onto P6 Drive in from of the Renaissance Hotel. Take your first left after the Renaissance Hotel and stay straight to the West parking lots of the stadium. Lighted electronic boards and directional signs will direct you to your event.

Directions from 495

Take Interstate 495 to Exit 36A onto Route 1 North. Follow Route 1 North approximately 4 miles to Gillette Stadium at Patriot Place on your right. Once you reach the Stadium, go through one set of lights and at the second set take a right onto P6 Drive. This road will lead you to the West stadium parking lots behind the Renaissance Hotel. Lighted electronic boards and directional signs will direct you to your event.

Parking and Entrance Details

Please park in in the West parking lots near the water tower and Renaissance Hotel. You will then enter through the W4 gate on the west side of the stadium, to get into the Putnam Club West.

Snehal Bhatt, PharmD, BCPS, Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Judy Cheng, PharmD, MPH, FCCP, BCPS, RPh, Professor and Chair, Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP, Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences and Clinical Pharmacist, Well Life

Erika Felix-Getzik, PharmD, Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Tim Fensky, BS in Pharmacy, Director of Pharmacy Operations, Advanced Wellness Pharmacy

Davida F. Kruger, MSN, APN, BC-ADM, Nurse Practitioner, Henry Ford Health System, Division of Endocrinology

Eden M. Miller, DO, D-ABOM, D-ACD, Founder, Diabetes Nation and CEO, Diabetes and Obesity Care LLC

Samar Nicolas, PharmD, CPPS, Assistant Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Phung C. On, PharmD, RPh, BCPS, Associate Professor of Pharmacy Practice, DEI Coordinator, and Academic Fellowship Coordinator in the School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, and Clinical Pharmacy Specialist, Codman Square Health Center

Prescription drug spending has a significant impact on the U.S. healthcare system, particularly for Medicare beneficiaries. National health expenditure data show that prescription drug spending rose by 11.4% to $449.7 billion in 2023, with nearly $60 billion attributed to out-of-pocket costs, according to GoodRx data. These high out-of-pocket expenses contribute to financial strain, medication non-adherence, and adverse health outcomes. The Inflation Reduction Act (IRA) seeks to address these challenges by reducing prescription drug costs for Medicare beneficiaries. This presentation will explore the key provisions of the IRA, its implications for patient care, and opportunities for pharmacist involvement.

At the completion of this activity, the participant should be able to:

• Understand the Key Provisions of the Inflation Reduction Act
• Discuss the impact of the Inflation Reduction Act on patient care
• Identify Opportunities for Pharmacist Involvement and Intervention
  

Presenters

Phung C. On, PharmD, RPh, BCPS, is an Associate Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Sciences (MCPHS) and the Diversity, Equity, and Inclusion (DEI) Coordinator for the School of Pharmacy – Boston. She also maintains a clinical practice at Codman Square Health Center in Boston, MA, where she serves as a Clinical Pharmacy Specialist, working collaboratively with the primary care team to manage patients with chronic diseases. Dr. On's professional background spans diverse pharmacy settings, including community pharmacy, long-term care, and hospital practice. She earned her Doctor of Pharmacy degree from MCPHS and completed a PGY1 Pharmacy Practice Residency at the University of North Carolina at Chapel Hill and AccessCare, a network of Community Care of North Carolina, focusing on ambulatory care, managed care, and transitions of care.

Activity Number: 0026-0000-25-006-L04-P | Knowledge-based
Topic Designator: Pharmacy Administration
Contact Hours: 1.0

An engaging and comprehensive exploration of continuous glucose monitoring (CGM) and its transformative role in diabetes management, the session is designed for pharmacists across community, hospital, and ambulatory care settings. This presentation highlights the essential knowledge and practical skills needed to support patients using CGM technology.

Learn how to interpret CGM metrics, such as time in range and glucose variability, and apply them to optimize medication regimens and improve patient outcomes. Discover strategies to educate patients about CGM devices, troubleshoot common challenges, and collaborate with interdisciplinary teams to enhance diabetes care.

This session will also address patient selection criteria, discuss the benefits and limitations of different CGM systems, and examine real-world case studies to provide actionable insights. By the end of this presentation, participants will feel confident in their ability to integrate CGM technology into their practice, regardless of their professional setting.

At the completion of this activity, the participant should be able to:

• Understand the fundamentals of CGM technology
• Identify the benefits and limitations of CGM
• Interpret CGM data for clinical decision-making
• Recognize the pharmacist's role in supporting CGM use
• Apply patient selection criteria for CGM use
• Promote collaborative care in diabetes management

Presenters

The Sugar Queens

Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP, is a professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences in Boston, MA where she teaches in the pharmacy and physician assistant programs. She is a clinical pharmacist/director of the Cardiometabolic Program at Well Life in Peabody, where she trains and precepts PharmD students, residents and fellows.

Dr. Goldman has been practicing for 35 years and is board certified in advanced diabetes management, is a Certified Diabetes Care and Education Specialist and a fellow of the American College of Clinical Pharmacists. She has presented at local, national and international pharmacy and medical conferences and has served on state and national public health and diabetes boards. She has received multiple internal and external awards for scholarship, teaching and service and has numerous publications in the areas of diabetes, cardiometabolic, renal disease and teaching/education.

Davida F. Kruger, MSN, APN-BC, BC-ADM, has been a certified nurse practitioner in diabetes for more than 30 years at Henry Ford Health System in Detroit, Michigan. Her role includes both clinical practice and research. She is board certified by the American Nurses Association Credentialing Center in Primary Care and by the American Association of Diabetes Educators in Advanced Diabetes Management. She is past Chair of the American Diabetes Associations Research Foundation and has served on the American Diabetes Association’s Research Policy Committee. She is also a past president, Health Care and Education of the American Diabetes Association. She served as editor of Diabetes Spectrum from 2005-2008. She served as the Editor In Chief of Clinical Diabetes from 2011-2016.

Davida has been a principal investigator on numerous research projects, authoring the book The Diabetes Travel Guide Second Edition (2006). Her awards include the American Diabetes Association’s Rachmiel Levine Award for Distinguished Service, Wendell Mayes' Award, and Award for Outstanding Service in Diabetes Research Funding. In addition to her ADA awards, she has been honored with the the 2014 Clara Ford Award for Nursing Excellence in Research and Education, the Florence Nightingale award for excellence in research and Wayne State University School of Nursing's 2014 Alumna of the year.

Eden M. Miller, DO, D-ABOM, D-ACD, received her medical degree from Kirksville College of Osteopathic Medicine in 1997. Returning to the Northwest, she completed her residency in Family Practice at East Moreland Hospital in Portland, Oregon. Recently completing her certification in Obesity management, she is the founder of Diabetes Nation a nonprofit organization, and CEO of Diabetes and Obesity Care LLC.

Dr. Miller cultivated a special interest in diabetes after contracting type-1 diabetes while in medical school. Out of that personal experience, her practice has extended into a sub-specialty in diabetes care. An impassioned speaker, Dr. Miller has given over 1250 lectures in the field of Diabetes to health care providers and patients alike, on subjects such as Diabetes Management, CGM Technology, Insulin Pump Therapy, Obesity and Metabolism intervention, Clinical Research, and Healthcare Policy. Her adage for care is that she “only succeeds as a provider if she turns patients into experts on their own disease.”

Activity Number: 0026-0000-25-002-L01-P | Application -based
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 2.0

Pharmacists provide a wide array of clinical services to patients. This program will discuss the concept of Standards of Care in pharmacy practice from a regulatory model perspective. The pharmacist training is not only clinical but requires a regulatory understanding of pharmacy practice.

The pharmacist’s regulatory competency has been assessed through the Multistate Pharmacy Jurisprudence Exam (MPJE). However, the recent development of the Uniform Pharmacy Jurisprudence Exam (UPJE) has given states an alternative. This session will explore the differences between each exam, and review the regulatory landscape and the most recently updated regulations and policies.

At the completion of this activity, the participant should be able to:

• Define the five steps for implementing Standards of Care in Pharmacy Regulations
• Explain the differences between the Multistate Pharmacy Jurisprudence Examination (MPJE) and the Uniform Pharmacy Jurisprudence Examination
• Interpret the most recent pharmacy regulation and policy changes within the New England Area

Presenter

Timothy Fensky, BS in Pharmacy, is the present Director of Pharmacy Operations at Advanced Wellness Pharmacy. Previously, he was the Chief Pharmacy Officer at Sullivan’s Health Care for over 25 years.

Timothy has held several leadership positions in the National Association of Boards of Pharmacy, where he was President and Chairperson. He is a former President and Board Member of the Massachusetts Board of Registration in Pharmacy and Massachusetts Independent Pharmacist Association. Currently, he is a member on the National Council of Prescription Drug Programs Board of Trustees. He has been recognized for his contributions to pharmacy and the community he's served, receiving the Nathan Goldberg Award and the Bowl of Hygeia from the Massachusetts Pharmacist Association.

Activity Number: 0026-0000-25-005-L03-P | Knowledge-based
Topic Designator: Pharmacy Law
Contact Hours: 1.0

Heart failure, coronary artery disease, and atrial fibrillation are three cardiac diseases that pharmacists play important roles in patient management. Research continues to explore the use of new medications and different optimization strategies of standard regimens to improve mortality and morbidity in these patients. It is important that pharmacists taking care of patients with cardiovascular diseases be up-to-date with the latest clinical evidence in order to provide the most optimal care for these patients.

This presentation provides know the latest guidelines and clinical trial data regarding new or unique pharmacological approaches in the management of patients with heart failure with preserved ejection fraction, post intervention of coronary artery disease, and anticoagulation for atrial fibrillation.

At the completion of this activity, the participant should be able to:

• Assess if Glucagon-like peptide 1 receptor agonists (GLP-1RAs) would be an appropriate therapy for improving cardiovascular outcomes for a patient with heart failure with preserved ejection fraction (HFpEF)
• Evaluate if mineralocorticoid receptor antagonist would be an appropriate therapy for improving cardiovascular outcomes for a patient with HFpEF
• Assess thrombosis and bleeding risk in patients who receive coronary artery stents
• Design an antiplatelet therapy regimen that balances thrombosis and bleeding risk in a patient who receives coronary artery stent placement
• Identify patients with atrial fibrillation requiring anticoagulation therapy based on the current atrial fibrillation guidelines
• Determine appropriate anticoagulation therapy for AFib patients with obesity and/or status post bariatric surgery using the guidelines and available literature

Presenters

Snehal Bhatt, PharmD, BCPS, is a Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Sciences and Clinical Pharmacist at the Beth Israel Deaconess Medical Center, where he practices in cardiovascular medicine. He has maintained his Board Certified Pharmacotherapy Specialist (BCPS) credential since 2003. Dr. Bhatt was awarded Fellow of the American Society of Health-System Pharmacists (ASHP) in 2017. As an active member of ASHP, Dr. Bhatt is a content matter expert and faculty member in ASHP’s BCPS recertification and preparatory course, a position he has held since 2015.

Dr. Bhatt is also actively involved in the American College of Cardiology (ACC) where his leadership roles include serving on the Cardiovascular Team (CVT) Leadership Council, CV Team Regional Director, and the CV Team Education Committee. He was awarded Associate of the American College of Cardiology (AACC) in 2018.

Judy W.M. Cheng, Pharm.D., MPH, FCCP, BCPS (AQ in Cardiology), is Professor of Pharmacy Practice and Chair of Department of Pharmacy Practice at the School of Pharmacy - Massachusetts College of Pharmacy and Health Science, Boston. Professor Cheng received her BS in Pharmacy Degree from University of Toronto and her PharmD from Philadelphia College of Pharmacy, also receiving a Master of Public Health Degree from Mount Sinai School of Medicine – New York University. She completed a clinical pharmacy residency at St. Michael’s Hospital in Toronto and a Fellowship in Cardiovascular Pharmacotherapy at the University of Sciences in Philadelphia.

Professor Cheng’s area of clinical practice and research interest is cardiovascular pharmacotherapy. She maintains an active clinical pharmacy practice in this area at Brigham and Women’s Hospital. In 2004, she was named Fellow of the American College of Clinical Pharmacy recognizing her contribution to the pharmacy profession.

Erika Felix Getzik, PharmD, is Professor of Pharmacy Practice in the Department of Pharmacy Practice at the School of Pharmacy - Boston, Massachusetts College of Pharmacy and Health Sciences. Professor Getzik received her Pharm D from the University of Pittsburgh. She completed her PGY-1 pharmacy practice residency at New England Medical Center (now Tufts Medical Center), and her PGY-2 in adult cardiology at the University of Pittsburgh Medical Center - Presbyterian Hospital.

Professor Getzik's area of clinical practice and research interest is adult ambulatory cardiovascular pharmacotherapy. She maintains an active clinical pharmacy practice in this area at MGB Newton-Wellesley Hospital.

Activity Number: 0026-0000-25-003-L01-P | Application-based
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1.0

Medication Safety in the Digital Age: Legal Considerations for Pharmacists

This continuing education explores the intersection of pharmacy law, digital health, and medication safety. Pharmacists play a pivotal role in leveraging digital health innovations to optimize patient care while ensuring compliance with regulatory standards. This program will provide participants with the foundational knowledge and evaluative skills necessary to navigate this evolving landscape.

Participants will learn about FDA-cleared technologies that can aid in managing specific medical conditions. The session will highlight the integration of clinical decision support systems and telepharmacy in reducing medication errors and enhancing patient care. Through case studies and practical examples, this program equips pharmacists to evaluate and recommend digital health solutions effectively, ensuring their safe application in diverse healthcare settings.

At the completion of this activity, the participant should be able to:

• Describe the relationship between medication safety, digital health, and pharmacy law in ensuring safe and effective patient care
• Identify examples of FDA-cleared digital health tools that pharmacists can recommend for the treatment of specific medical conditions
• Evaluate the impact of digital health innovations, such as clinical decision support systems and telepharmacy on minimizing medication errors
• Describe the role of the only FDA-approved digital health app, EndeavorRx®, in managing ADHD, its FDA regulation as digital therapeutic, and its impact on medication safety

Presenter

Samar Nicolas, PharmD, CPPS, is an Assistant Professor of Pharmacy Practice at Massachusetts College of Pharmacy and Health Sciences. Dr. Nicolas completed a fellowship in Medication Safety, Quality, and Informatics at Saint Vincent Hospital/ Massachusetts College of Pharmacy and Health Sciences University and is a Certified Professional in Patient Safety (CPPS). Dr. Nicolas is the recipient of the Academic of The Year Award 2020 – 2021.

Passionate about education and innovation, Dr. Nicolas teaches medication safety, informatics, artificial intelligence, and digital health within the pharmacy curriculum, equipping future pharmacists to navigate the complexities of modern healthcare systems. Dr. Nicolas also serves as a co-coordinator for the Medication Safety Certificate at Massachusetts College of Pharmacy and Health Sciences University.

Release Date: March 6, 2025
Expiration Date: March 6, 2026
Activity Number: 0026-0000-25-004-H03-P | Knowledge-based
Contact Hours: 1.0 (Home Study)